Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Contraception

Showing results (361-370 of 7,857) with videos related to

Pageof 786
Sort By:
Contraception|December 1, 1996
Synergistic effect of gramicidin and EDTA in inhibiting sperm motility and cervical mucus penetration in vitroA S Bourinbaiar, C H Lee
Contraception|December 1, 1996
Isolation of a non-steroidal contragestative agent from Sri Lankan marine red alga, Gelidiella acerosaG A Premakumara, W D Ratnasooriya, L M Tillekeratne
Contraception|December 1, 1995
When is it safe to switch from oral contraceptives to hormonal replacement therapy?V D Castracane, T Gimpel, J W Goldzieher
Contraception|January 1, 1997
Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the ratB Dao, G Vanage, X J Li, et al.
Contraception|January 1, 1997
Reversible changes in the content of cellular and microtubular tubulin in spermatogenic cells after gossypol treatmentC S Teng
Contraception|March 1, 1997
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptivesP J Schwingl, J Shelton
Contraception|March 1, 1997
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and toleranceJ Endrikat, U Müller, B Düsterberg
Contraception|March 1, 1997
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG)D F Archer, R Maheux, A DelConte, et al.
Contraception|March 1, 1997
The use of misoprostol for termination of early pregnancyJ L Carbonell, L Varela, A Velazco, et al.
Contraception|March 1, 1997
Bias in studies of venous thromboembolism in relation to the use of new formulations of oral contraceptivesN S Weiss
Pageof 786

Showing results (361-370 of 7,857) with videos related to

Sort By:
Pageof 786
Contraception|December 1, 1996
Synergistic effect of gramicidin and EDTA in inhibiting sperm motility and cervical mucus penetration in vitroA S Bourinbaiar, C H Lee
Contraception|December 1, 1996
Isolation of a non-steroidal contragestative agent from Sri Lankan marine red alga, Gelidiella acerosaG A Premakumara, W D Ratnasooriya, L M Tillekeratne
Contraception|December 1, 1995
When is it safe to switch from oral contraceptives to hormonal replacement therapy?V D Castracane, T Gimpel, J W Goldzieher
Contraception|January 1, 1997
Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the ratB Dao, G Vanage, X J Li, et al.
Contraception|January 1, 1997
Reversible changes in the content of cellular and microtubular tubulin in spermatogenic cells after gossypol treatmentC S Teng
Contraception|March 1, 1997
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptivesP J Schwingl, J Shelton
Contraception|March 1, 1997
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and toleranceJ Endrikat, U Müller, B Düsterberg
Contraception|March 1, 1997
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG)D F Archer, R Maheux, A DelConte, et al.
Contraception|March 1, 1997
The use of misoprostol for termination of early pregnancyJ L Carbonell, L Varela, A Velazco, et al.
Contraception|March 1, 1997
Bias in studies of venous thromboembolism in relation to the use of new formulations of oral contraceptivesN S Weiss
Pageof 786